Filing Details
- Accession Number:
- 0000899243-22-021396
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-07 19:37:48
- Reporting Period:
- 2022-06-06
- Accepted Time:
- 2022-06-07 19:37:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1587221 | Zosano Pharma Corp | ZSAN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501959 | Steven Lo | C/O Zosano Pharma Corporation 34790 Ardentech Court Fremont CA 94555 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-06 | 442 | $0.71 | 13,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
- Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.
Billionaire Hedge Funds
